• 1
    Anderson KO, Getto CJ, Mendoza TR, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003;25:307-318.
  • 2
    Parker KP, Bliwise DL, Ribeiro M, et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol. 2008;26:2464-2472.
  • 3
    Sela RA, Watanabe S, Nekolaichuk CL. Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care. 2005;3:23-31.
  • 4
    Owen DC, Parker KP, McGuire DB. Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncol Nurs Forum. 1999;26:1649-1651.
  • 5
    Kuo H, Chiu M, Liao W, Hwang SL. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. J Formos Med Assoc. 2009;105:64-69.
  • 6
    Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage. 2002;24:471-480.
  • 7
    Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 2000;14:275-290.
  • 8
    Sandadi S, Frasure H, Broderick MJ, Waggoner SE, Miller JA, von Gruenigen VE. The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol Oncol. 2011;123:351-355.
  • 9
    Ancoli-Israel S, Liu L, Marler MR, et al. Fatigue, sleep and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14:201-209.
  • 10
    Thomas K, Bower J, Hoyt MA, Sepah S. Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psychooncology. 2010;19:767-776.
  • 11
    Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998;16:1380-1387.
  • 12
    American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
  • 13
    Costanzo ES, Lutgendorf SK, Rothrock NE, Anderson B. Coping and quality of life among women extensively treated for gynecologic cancer. Psychooncology. 2006;15:132-142.
  • 14
    Lin EM, Aikin JL, Good BC. Premature menopause after cancer treatment. Cancer Pract. 1999;7:114-121.
  • 15
    Spiegel D. Cancer and depression. Br J Psychiatry Suppl. 1996;168:109-116.
  • 16
    Palesh OG, Collie K, Batichok D, et al. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2007;75:37-44.
  • 17
    Bodourka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78:302-308.
  • 18
    Hipkins J, Whitworth M, Tarrier N, Jayson G. Social support, anxiety, and depression after chemotherapy for ovarian cancer: a prospective study. Br J Health Psychol. 2004;9:569-581.
  • 19
    Price MA, Zachariae R, Butow PN, et al. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer. 2009;45:3262-3270.
  • 20
    Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
  • 21
    Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45:5-13.
  • 22
    Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage. 2004;27:140-148.
  • 23
    Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53:737-740.
  • 24
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
  • 25
    Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the center for epidemiological studies depression scale (CES-D). J Psychosom Res. 1999;46:437-443.
  • 26
    Schroevers MJ, Sanderman R, van Sonderen E, Ronchor AV. The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depress and positive affect in cancer patients and healthy reference subjects. Qual Life Res. 2000;9:1015-1029.
  • 27
    Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47:305-306.
  • 28
    Lutgendorf SK, Mullen-Houser E, Russell D, et al. Preservation of immune function in cervical cancer patients during chemotherapy using a novel integrative approach. Brain Behav Immun. 2010;24:1231-1240.
  • 29
    Bradley S, Rose S, Lutgendorf S. Quality of Life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol. 2006;100:479-486.
  • 30
    Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
  • 31
    Rubin S, ed. Society of Gynecologic Oncologists: Chemotherapy of Gynecologic Cancers. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
  • 32
    Chou C, Bentler PM. Model modification in covariance structure modeling: a comparison among likelihood ratio, lagrange multiplier, and wald tests. Multivariate Behav Res. 1990;25:115-136.
  • 33
    Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Stat Med. 2000;19:1793-1819.
  • 34
    Kalueff AV, Nutt DJ. Role of GABA in anxiety and depression. Depress Anxiety. 2007;24:495-517.
  • 35
    Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083-1152.
  • 36
    Berk M. Sleep and depression: theory and practice. Aust Fam Physician. 2009;38:302-304.
  • 37
    Goff BA, Mandel LS, Melacon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291:2705-2712.
  • 38
    Lutgendorf SK, Weinrib AZ, Penedo F, et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol. 2008;26:4820-4827.
  • 39
    Tempfer C, Zeisler H, Sliutz G, Haeusler G, Hanzal E, Kainz C. Serum evaluation of interleukin 6 in ovarian cancer patients. Gyncol Oncol. 1997;66:27-30.
  • 40
    Clevenger L, Schrepf A, Christensen D, et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun. 2012;26:1037-1044.
  • 41
    Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communications for understanding behavior, mood, and cognition. Psychol Rev. 1998;105:83-107.
  • 42
    Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun. 2002;16:503-512.
  • 43
    Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004;8:119-132.
  • 44
    Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone. 2004;6(suppl 1D):S15-S21.
  • 45
    Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry. 2008;165:1543-1550.
  • 46
    Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006;25:3-14.
  • 47
    Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31:489-495.
  • 48
    Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress, and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12:278-285.
  • 49
    Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol. 2005;23:6083-9096.